Analyst Ratings for Editas Medicine (EDIT)
EDIT Rating Summary
EDIT Price Target Summary
- Highest: $6.00 (Baird)
- Lowest: $4.00 (Evercore ISI)
- Average: $4.72
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$4.72 (+136%)
* Over Last 12-Mos
Rating Score: 3.7 / 10
Percentile Rank: 35%
Avg. $ Target:
$4.72 (+136%)
* Over Last 12-Mos
Rating Score: 3.7 / 10
Percentile Rank: 35%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/25/2025 | Evercore ISI | Jonathan Miller | New Coverage | Outperform (N/A) |
4.00 (N/A) |
2.80 (2.00) |
-28.57% | Details |
| 4/28/2025 | H.C. Wainwright » Updated 9/5/2025 |
Mitchell S. Kapoor | New Coverage | Buy (N/A) |
5.00 (N/A) |
1.54 (2.00) |
29.87% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
